Clinical Trial Update: Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing arbaclofen to placebo in children and adolescents with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Arbaclofen (arbaclofen)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED